RT @ProfJDChalmers: Open access- Single Inhaler triple therapy in patients with COPD - a systematic review https://t.co/oDiHJiwTW0 Bottom…
RT @ProfJDChalmers: Open access- Single Inhaler triple therapy in patients with COPD - a systematic review https://t.co/oDiHJiwTW0 Bottom…
Open access- Single Inhaler triple therapy in patients with COPD - a systematic review https://t.co/oDiHJiwTW0 Bottom-line, single inhaler triple is modestly effective at reducing exacerbations compared to dual therapy (ICS/LABA, LABA/LAMA) in exacerbati
#respiratoryresearch Single-inhaler triple therapy in patients with chronic obstructive… https://t.co/AkZYLbcAAq
RT @RespiratoryBMC: New article: Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review…
RT @JuanMarcoFigue1: The decision to prescribe triple therapy should consider patient phenotype, magnitude of benefit and increased risk of…
RT @RespiratoryBMC: New article: Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review…
RT @RespiratoryBMC: New article: Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review…
RT @RespiratoryBMC: New article: Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review…
@mlaucho @Majito25MD
RT @RespiratoryBMC: New article: Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review…
RT @RespiratoryBMC: New article: Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review…
New article: Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review https://t.co/Kqvy1owumg